# Providing Regulatory Submissions in Electronic and Non-Electronic Format—Promotional Labeling and Advertising Materials for Human Prescription Drugs - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/providing-regulatory-submissions-in-electronic-and-non-electronic-formatpromotional-labeling-and-advertising-materials-for-human-prescription-drugs/505d9bf5-96ba-4f03-a291-64f5c289be51

> FDA guidance document: Providing Regulatory Submissions in Electronic and Non-Electronic Format—Promotional Labeling and Advertising Materials for Human Prescription Drugs. Issue date: April 11, 2022. Get complete insights and analysis.

---

## Details

- Title: Providing Regulatory Submissions in Electronic and Non-Electronic Format—Promotional Labeling and Advertising Materials for Human Prescription Drugs
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-04-11
- Last Changed: 2022-04-11
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2015-D-1163">FDA-2015-D-1163</a>

## Related Documents

- [Providing Submissions in Electronic Format — Postmarketing Safety Reports](https://www.globalkeysolutions.net/guidances/guidance-document/providing-submissions-in-electronic-format-postmarketing-safety-reports/4ad827be-5b2f-4a35-a05b-6c58d6dbc5ff)
- [Presenting Quantitative Efficacy and Risk Information in  Direct-to-Consumer (DTC) Promotional Labeling and Advertisements](https://www.globalkeysolutions.net/guidances/guidance-document/presenting-quantitative-efficacy-and-risk-information-in-direct-to-consumer-dtc-promotional-labeling-and-advertisements/bb6d5d7c-0aa7-47cd-9c04-8a080c2201b7)
- [Special Protocol Assessment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/special-protocol-assessment-guidance-for-industry/2565ab98-6128-47ba-b033-f84934855d60)